Form 4 for SPRY ARS Pharmaceuticals, Inc.
Accepted 2024-04-24 00:00:00 ET · period of report 2024-04-23 · accession 0001415889-24-011471 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-24 | 2024-04-23 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $1.06 | +131.0K | 3.36M | +4% | +$139.0K |
| DM | 2024-04-24 | 2024-04-23 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $0.00 | -131.0K | 34.5K | -79% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-23 | M | A | 48,260 | $1.44 | 3,407,847 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-23 | M | A | 82,733 | $0.84 | 3,359,587 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-04-23 | M | D | 82,733 | $0.00 | 0 | D | $0.84 · — to 2029-12-16 | 82,733 Common Stock | (F4) 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date. |
| 4 | Derivative | Stock Option (right to buy) | 2024-04-23 | M | D | 48,260 | $0.00 | 34,473 | D | $1.44 · — to 2031-12-13 | 48,260 Common Stock | (F4) 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date. |